Raltegravir and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Raltegravir (raltegravir), especially for people who are male, 40-49 old, also take Dexamethasone, and have Hiv infection.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Raltegravir. It is created by eHealthMe based on reports of 5,050 people who have side effects when taking Raltegravir from the FDA, and is updated regularly.

What is Raltegravir?

Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 5,054 Raltegravir users. Check the latest studies of Raltegravir.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,660 drugs and 2,501 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

5,050 people reported to have side effects when taking Raltegravir.
Among them, 11 people (0.22%) have Hyperglycemia.

Among these 11 people:

What is the gender of people who have Hyperglycemia when taking Raltegravir? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Hyperglycemia when taking Raltegravir? *

What are other drugs people take besides Raltegravir? *

What are other side effects people have besides Hyperglycemia? *

Acute Kidney Failure: 2 people, 18.18%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 18.18%
Oedema (fluid collection in tissue): 2 people, 18.18%
Diabetes: 2 people, 18.18%
Pathogen Resistance: 2 people, 18.18%
Diabetic Hyperosmolar Coma (diabetes coma due to extremely high blood sugar (glucose) levels; extreme lack of water (dehydration)): 2 people, 18.18%
Confusional State: 1 person, 9.09%
Cardiotoxicity (damage to the heart muscle): 1 person, 9.09%
Dehydration (dryness resulting from the removal of water): 1 person, 9.09%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 1 person, 9.09%

What are the existing conditions these people have? *

Hiv Infection: 8 people, 72.73%
Hodgkin's Lymphoma (cancer originating from white blood cells): 2 people, 18.18%
Pneumonia: 1 person, 9.09%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Hepatitis C: 1 person, 9.09%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 9.09%
Blood Glucose Increased: 1 person, 9.09%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Raltegravir and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Raltegravir:

Raltegravir (5,054 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Raltegravir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,660 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,501 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.